OBJECTIVE: To test whether a higher fasting insulin concentration is associated with a lower rate of weight gain over six to seven years. DESIGN: Two longitudinal epidemiologic cohorts including blacks and whites. SUBJECTS: The Coronary Artery Risk Development in Young Adults (CARDIA) Study examined subjects aged 18±30 y in 1985±86 and 1992±93 (n 3636), and the Atherosclerosis Risk in Communities (ARIC) Study examined subjects aged 45±64 y in 1987±89 and 1993±95 (n 11179). MEASUREMENTS: In each study, fasting insulin at baseline and weight change during follow-up were measured in participants without diabetes. RESULTS: In whites and black men in CARDIA, there was a positive age-adjusted association between baseline insulin and weight change, although weight change was not entirely monotonic across the insulin quartiles. In these racegender-groups, the linear regression coef®cients indicated that each 50 pmolaL increment of baseline insulin was associated (P`0.05) with approximately 0.10 kgay greater rate of weight gain (95% con®dence intervals (CI) for this estimate in kgay were 0.023±0.187 for white women, 0.015±0.150 for black men, and 0.011±0.158 for white men). The association was eliminated entirely with adjustment for baseline weight. In contrast, among whites and black women in ARIC, the association was negative, with the linear regression coef®cients suggesting that each 50 pmolaL higher fasting insulin concentration was associated (P`0.05) with a 0.03±0.10 kgay lower rate of weight gain (95% CI for this estimate in kgay were 70.133 to 70.061 for black women, 70.106 to 70.054 for white women, and 70.055 to 70.009 for white men). This ®nding was generally strengthened by adjustment for baseline body mass index (BMI). CONCLUSIONS: A higher fasting insulin concentration is associated modestly with a lower rate of weight gain in ARIC, but not in CARDIA.
Introduction
Insulin resistance and hyperinsulinemia are common consequences of obesity. Eckel 1 proposed that insulin resistance is an adaptation for maintaining stable weight, that is, preventing additional weight gain. Three recent longitudinal studies of Pima Indians 2 and of Hispanic and non-Hispanic whites, 3, 4 found markers of insulin resistance (that is, euglycemic clamp 2 or fasting insulin 3, 4 ) among nondiabetics to be associated inversely with the rate of weight gain. A fourth prospective study of Japanese-American men found fasting insulin not associated with weight gain overall. In fact, fasting insulin and C-peptide were associated positively, and insulin secretion negatively, with gain of intra-abdominal fat measured by computed tomography. 5, 6 We sought to investigate whether fasting serum insulin is associated inversely with weight gain in two additional longitudinal studies with varied recruitment strategies, consisting of markedly different age ranges and from well-distributed regions of the US.
Methods
Coronary Artery Risk Development in Young Adults (CARDIA) Study and whites across a broad range of education levels. CARDIA performed examinations at baseline (Year 0), Year 2, Year 5 and Year 7 (n 4086, 80% return rate). In Year 0, CARDIA measured fasting serum glucose by the hexokinase method and fasting insulin by a modi®ed immunoassay technique. 8 At each examination, technicians used a standardized protocol to measure body weight (in light clothing) to the nearest 0.2 kg and height (without shoes) to the nearest 0.5 cm.
Atherosclerosis Risk in Communities (ARIC) Study
From 1987±1989, the ARIC Study 9 examined a cohort of 15 800 men and women, aged 45±64 y, selected by probability sampling from Forsyth County, NC; Jackson, MS (blacks only); the northwestern suburbs of Minneapolis, MN and Washington County, MD. ARIC re-examined the cohort after three years in 1990±1992 and after six years in 1993±1995 (n 12 885, 86% return rate). At baseline, ARIC measured fasting serum glucose by the hexokinase method and fasting insulin by a radioimmunoassay ( 125 Insulin Kit; Cambridge Medical Diagnostics, Inc., Billerica, MA). 10 At each examination, technicians made standardized measurements of weight to the nearest 0.4 kg and height to the nearest cm, with the subject wearing only a scrub suit.
Statistical methods
We restricted the analysis to non-pregnant black and white participants who had no history of, or treatment for, diabetes at baseline; had a fasting glucose`140 mgadl; had non-missing baseline fasting insulin values and had weights from both baseline and follow-up (1992±93 in CARDIA, 1993±95 in ARIC). After exclusions, the ®nal sample sizes were 3636 for CARDIA and 11 197 for ARIC. In accordance with two previous studies, 2, 3 we hypothesized that the longitudinal rate of weight change would be associated inversely with the baseline concentration of fasting insulin. We also used study-, gender, and race-speci®c linear regression models to predict annual weight change from baseline insulin, as a continuous variable. These models were run with, and without, adjustment for baseline weight. The regression coef®cients were standardized to estimate the annual weight change per 50 pmolaL higher level of fasting insulin (the approximate interquartile range for both studies). SAS (Statistical Analysis System, Cary, NC) was used for analysis.
Results
CARDIA and ARIC included both black and white participants ( Table 1 ). The average baseline age was 25 y in CARDIA and 54 y in ARIC. CARDIA and ARIC used different insulin assays, but the means and distributions of baseline fasting insulin were similar between the two studies. Baseline weight averaged 6± 8 kg less in CARDIA than in ARIC, but the longitudinal rate of weight gain was greater in CARDIA participants (approximately 1 kgay) than in ARIC participants (less than 0.5 kgay). The cross-sectional BMI body mass index.
Fasting insulin and rate of weight gain A R Folsom et al
Pearson correlation coef®cient between baseline BMI and fasting insulin was similar in the two studies, ranging from 0.48±0.51 across the four race-gender groups in CARDIA and from 0.41±0.55 in ARIC. Figure 1 shows study-, race-, and gender-speci®c rates of age-adjusted weight change according to study-speci®c quartiles of insulin. Patterns of association contrasted signi®cantly between CARDIA and ARIC. In whites and black men in CARDIA, there was a positive association between baseline insulin and weight change, although weight change was not entirely monotonic across the insulin quartiles. In these race-gender-groups, the linear regression coef®cients (see * b in Figure 1 ) indicated that each 50 pmolaL increment of insulin was associated (P`0.05) with an approximately 0.1 kgay greater rate of weight gain. However, adjustment for baseline weight uniformly eliminated the association between weight change and insulin in CARDIA (see ** b in Figure 1 ). In contrast, among whites and black women in ARIC, the association was negative, with the linear regression coef®cients suggesting that each 50 pmolaL higher fasting insulin concentration was associated (P`0.05) with a 0.03±0.10 kgay lower rate of weight gain. However, adjustment for baseline weight strengthened these associations. There was no signi®cant linear association between fasting insulin and weight gain in ARIC black men or in CARDIA black women. When analyses were repeated pooling blacks and whites, however, insulin by race interaction terms was not signi®cant (P b 0.05), suggesting no real difference in the association for whites vs blacks. Because smoking affects weight, we also repeated analyses after excluding those who Fasting insulin and rate of weight gain A R Folsom et al changed smoking status and regression coef®cients were virtually unchanged. Two obvious differences between the CARDIA and ARIC study populations are age and mean weight, so we explored these issues further in the regression models. In neither CARDIA nor ARIC was there a signi®cant interaction between baseline insulin and age in determining weight gain. When both samples were restricted to non-overweight participants (BMI`27.3 in women and`27.8 in men), 11 the sign of the beta coef®cient for the association of weight change with baseline insulin (unadjusted for baseline weight) was positive for all race-gender groups in CARDIA and negative for three of four race-gender groups in ARIC, although most of the beta coef®cients were no longer statistically signi®-cant.
We repeated the regression analysis strati®ed by study-and gender-speci®c quartiles of baseline weight and adjusting for smoking, race and age ( Table 2) . As expected, mean fasting insulin levels were greater across each successive quartile of baseline weight. In CARDIA, there was no consistent association, after covariate adjustment, between fasting insulin and weight change within quartiles of baseline weight. A formal test of statistical interaction between fasting insulin and baseline weight in relation to weight change was marginally statistically signi®cant among CARDIA men (P 0.04) and was highly signi®cant among CARDIA women (P`0.001), in the latter case primarily due to a strong negative association between fasting insulin and weight change in the highest weight quartile (Table 2 ). In ARIC, the association between fasting insulin and weight change was negative within most baseline weight quartiles. Within the upper three weight quartiles, the linear regression coef®cients indicated there was 0.026±0.148 kgay less weight gain for each 50 pmolaL increment of fasting insulin. Interaction terms for fasting insulin by baseline weight were highly statistically signi®cant in ARIC women (P`0.001) but not in ARIC men (P 0.43).
Discussion
Insulin resistance may lead to less effective fat storage and increased fat oxidation. 1 In people free of diabetes, fasting insulin is a reasonably good marker of insulin resistance (r 70.65 vs glucose uptake by euglycemic clamp) 12 and is feasibly measured in large epidemiologic studies. Therefore, we hypothesized that in both CARDIA and ARIC, higher baseline fasting insulin would be associated with lower weight gain. Three previous studies generally have supported this hypothesis. 2±4 (1) The Pima study examined subjects aged 18±41 y (mean 25) with a mean BMI of 33 (range: 18±60) in men and 36 (range 20±63) in women, and used the euglycemic clamp to directly measure insulin resistance. 2 The percent weight change per year correlated with glucose disposal at submaximally-(r 0.19) and maximallystimulating (r 0.34) insulin concentrations independent of gender, age, initial weight and 24h energy expenditure.
2 ( 2) The San Luis Valley Study, which examined subjects aged 20±74 y (mean 53) with a mean BMI of 26 (s.d. 3.6) in men and 25 (s.d. 4.4) in women, employed fasting insulin.
3 ( 3) The San Antonio Heart Study, which examined subjects aged 25±64 y (mean 44) with a mean BMI of 27 in men and 26 in women, also used fasting insulin. 4 In the latter two studies, the inverse association between fasting insulin and weight change, appeared to be strongest in the most overweight participants. In contrast, a study of non-diabetic Japanese-American men, who averaged 61 y with BMI of 24.8, found low insulin secretion, high fasting insulin, and high Cpeptide levels associated with greater gain of intraabdominal fat; however, none of these insulin indices was related to overall weight gain. 5 Our ®ndings were generally consistent for blacks and whites, but contrasted by study. ARIC results supported the hypothesis, suggesting each 50 pmolaL higher fasting insulin concentration was associated with a 0.03±0.10 kgay lower age-adjusted rate of weight gain. This ®nding was somewhat stronger when adjusted for baseline weight. CARDIA, in contrast, showed a higher insulin concentration was associated with an increased rate of weight gain overall. However, associations in CARDIA were eliminated after stratifying or adjusting for baseline BMI. In neither ARIC or CARDIA were the associations between insulin and weight change very strong.
We do not know why CARDIA ®ndings differed from ARIC and the previous investigations. 2±4 The insulin assays differed between CARDIA and ARIC, but cross-sectional associations between insulin and BMI were similar in the two cohorts. One possible explanation is that the hypothesis tested, that a higher insulin concentration mitigates against weight gain, may be wrong. Clinical studies, in fact, have shown exogenous insulin treatment may increase weight gain. 13, 14 In CARDIA, for which we have a followup fasting insulin measurement, people who lost weight had a fall in insulin concentration. 15 This suggests weight determines insulin, not vice-versa. On the other hand, Yost et al 16 reported that a greater improvement in insulin sensitivity with weight loss is strongly positively correlated with the amount of weight subsequently regained. 16 Two studies also have suggested that reduced insulin secretion may be associated with greater gain in weight 6 or intraabdominal fat. 5 Another possible explanation for differing CARDIA and ARIC results is an interaction with age; that is, the hypothesis may be true only in older people. However, the results of the Pima Study, whose participants were young and quite obese, were more Fasting insulin and rate of weight gainsimilar to ARIC than CARDIA. It also could be that hyperinsulinemia is a better marker of insulin resistance in older people. Thus, ARIC participants may be more insulin resistant at a given insulin concentration than are CARDIA participants. However, the absence of an interaction of insulin with age within each cohort suggests an age-related decline in insulin sensitivity, per se, may not be an important explanation of differences. A single study including the ages 18±64 y would be needed to better test for an insulin by age interaction.
We lacked direct measures of fat mass and information on duration of obesity. There may be a threshold level and duration of obesity, not yet achieved by most CARDIA participants, above which insulin resistance may lead to reduced weight gain. This may also be the result of prolonged hyperinsulinemia leading to physiologic changes not measured here, such as visceral fat accumulation with concomitant metabolic consequences andaor changes in peripheral muscle composition.
A ®nal possibility is that the contrast between CARDIA's and other studies' data ®ts the`b-cell exhaustion' hypothesis. In people with longstanding obesity, insulin resistance and a depleted pancreatic bcell reserve, insulin levels may begin to fall (though still elevated for a time). In these people, falling insulin may be serving to deliver glucose to muscle and liver rather than produce adipose. In contrast, in people with shorter-term obesity, as perhaps is the case in CARDIA, the replete b-cell reserve may deliver relatively more insulin, leading to fat deposition.
In conclusion, a higher fasting insulin concentration predicts a lower rate of weight gain in our cohort of middle-aged adults, but not in our cohort of young adults. To further sort out the temporal relation, studies are needed with multiple longitudinal measures of weight and insulin level ± or better yet, direct measures of insulin resistance.
Addendum
After this paper was accepted, Odeley, et al. reported that fasting insulin was positively associated with weight gain over 9 years among Pima Indian children. 17 This is consistent with our ®nding for young adults in CARDIA, further emphasizing an agerelated difference in the relation of insulin and weight gain. 17 Odeley OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997; 46: 1341± 1345.
